Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

Papa G, Mandelli F, Anselmo A P, De Luca A M, Maurizienrici R, Mauro F, Testi A M, Amadori S, Biagini C

Eur J Cancer Clin Oncol. 1982 Sep;18(9):803-6. doi: 10.1016/0277-5379(82)90188-2.

Abstract

摘要

相似文献

Eur J Cancer Clin Oncol. 1982 Sep;18(9):803-6. doi: 10.1016/0277-5379(82)90188-2.

Cancer Chemother Pharmacol. 1979;2(2):101-5. doi: 10.1007/BF00254081.

J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.

Semin Oncol. 1990 Feb;17(1 Suppl 2):2-6.

Med Pediatr Oncol. 1997 Jul;29(1):23-7. doi: 10.1002/(sici)1096-911x(199707)29:1<23::aid-mpo4>3.0.co;2-u.

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):947-51.

Ann Intern Med. 1982 Feb;96(2):139-43. doi: 10.7326/0003-4819-96-2-139.

J Ky Med Assoc. 2004 Mar;102(3):104-6.

Cancer. 1978 Jun;41(6):2107-11. doi: 10.1002/1097-0142(197806)41:6<2107::aid-cncr2820410606>3.0.co;2-l.

N Engl J Med. 1993 Apr 8;328(14):1045; author reply 1045-6.

Drugs. 1985 Oct;30(4):355-67. doi: 10.2165/00003495-198530040-00004.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。